Navigation Links
Cancer-fighting agent heads for clinical trials

Wauwatosa, Wis. - Now that Christopher Chitambar, a physician researcher at the Medical College of Wisconsin Cancer Center, has found that a gallium compound might be an effective anti-tumor agent, it's time for the test.

If the compound is found to be safe and effective in forthcoming clinical trials, it could treat forms of non-Hodgkin's lymphoma ......

Full article >>> ddress iron-dependent malignant cell growth and to improve the efficacy of cancer chemotherapy by interrupting the flow of iron and other metals within cells.

At the moment, the cellular basis for tumor cell resistance to gallium nitrate is not well understood, but Chitambar's research has found gallium maltolate to be a unique formulation that bypasses the cellular pathways involved in g......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 12/07/06


Related biology technology :

1. Brilliant Core Reagent Kits for QPCR and QRT-PCR
2. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
3. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
4. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
5. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
6. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
7. TransMessenger Transfection Reagent
8. Effectene Transfection Reagent provides efficient gene delivery to primary neuronal cell cultures
9. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
10. Effectene Transfection Reagent
11. PolyFect Transfection Reagent
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)... 12, 2017   Protein Sciences Corporation , ... Flublok Influenza Vaccine ®, announced today that ... good safety results and induced strong neutralizing antibodies ... product is expected to advance into human clinical ... the Institute of Technology in Immunobiologicals of the ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... rapid adoption of Limfinity® Cloud, RURO has enhanced the platform to accommodate ... groups, federated login, rapid data searching, and more. In addition to these ...
(Date:1/11/2017)... ... January 11, 2017 , ... As a ... Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand the ravages ... discovery. , Now, as an assistant professor of biology and biotechnology at Worcester ...
(Date:1/11/2017)... Yorba Linda, Ca (PRWEB) , ... January 11, ... ... in the U.S. each year and costing healthcare systems more than $23.7 billion, ... patients while controlling costs. , Among the most common sepsis-causing pathogens are ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):